Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shubulade Smith

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Schizophrenia Research|April 14, 2019
Outcome of a psychosocial health promotion intervention aimed at improving physical health and reducing alcohol use in patients with schizophrenia and psychotic disorders (MINT)Jeanette Westman, Jonas Eberhard, Fiona P Gaughran, et al.
BMC Psychiatry|October 18, 2013
Improving physical health and reducing substance use in psychosis--randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trialFiona Gaughran, Daniel Stahl, Khalida Ismail, et al.
BMC Psychiatry|December 30, 2017
Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT)Fiona Gaughran, Daniel Stahl, Khalida Ismail, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 27, 2019
Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort studyFiona Gaughran, Daniel Stahl, Dominic Stringer, et al.
JAMA Network Open|December 28, 2021
Effect of Vitamin D Supplementation on Outcomes in People With Early Psychosis: The DFEND Randomized Clinical TrialFiona Gaughran, Dominic Stringer, Gabriella Wojewodka, et al.
BMC Psychiatry|December 24, 2017
Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotionMargaret Heslin, Anita Patel, Daniel Stahl, et al.
Trials|January 8, 2020
Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trialFiona Gaughran, Dominic Stringer, Michael Berk, et al.
Biological Psychiatry|October 22, 2016
An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode PsychosisEvangelos Vassos, Marta Di Forti, Jonathan Coleman, et al.
The Lancet. Psychiatry|September 27, 2017
The WPA-Lancet Psychiatry Commission on the Future of PsychiatryDinesh Bhugra, Allan Tasman, Soumitra Pathare, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Schizophrenia Research|April 14, 2019
Outcome of a psychosocial health promotion intervention aimed at improving physical health and reducing alcohol use in patients with schizophrenia and psychotic disorders (MINT)Jeanette Westman, Jonas Eberhard, Fiona P Gaughran, et al.
BMC Psychiatry|October 18, 2013
Improving physical health and reducing substance use in psychosis--randomised control trial (IMPACT RCT): study protocol for a cluster randomised controlled trialFiona Gaughran, Daniel Stahl, Khalida Ismail, et al.
BMC Psychiatry|December 30, 2017
Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT)Fiona Gaughran, Daniel Stahl, Khalida Ismail, et al.
The British Journal of Psychiatry : the Journal of Mental Science|July 27, 2019
Effect of lifestyle, medication and ethnicity on cardiometabolic risk in the year following the first episode of psychosis: prospective cohort studyFiona Gaughran, Daniel Stahl, Dominic Stringer, et al.
JAMA Network Open|December 28, 2021
Effect of Vitamin D Supplementation on Outcomes in People With Early Psychosis: The DFEND Randomized Clinical TrialFiona Gaughran, Dominic Stringer, Gabriella Wojewodka, et al.
BMC Psychiatry|December 24, 2017
Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotionMargaret Heslin, Anita Patel, Daniel Stahl, et al.
Trials|January 8, 2020
Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): a protocol for a randomised, double-blind, placebo-controlled, parallel-group trialFiona Gaughran, Dominic Stringer, Michael Berk, et al.
Biological Psychiatry|October 22, 2016
An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode PsychosisEvangelos Vassos, Marta Di Forti, Jonathan Coleman, et al.
The Lancet. Psychiatry|September 27, 2017
The WPA-Lancet Psychiatry Commission on the Future of PsychiatryDinesh Bhugra, Allan Tasman, Soumitra Pathare, et al.
Pageof 6